NIH #2R01CA212424-06A1
Role of the histone modifier MLL3 mutation in breast cancer cell plasticity
- Amount
- $420K
- Period
- 2020-03-01 → 2031-05-31
- PIs
- 1
- Est. capacity / PI
- ~3 students
Cancer Cells and Metastasis · Oncology
16 total · 9 active
NIH #2R01CA212424-06A1
NIH #1R01CA306893-01
NIH #5R01CA289734-02
Student capacity is a rough estimate from remaining award size, split equally among PIs. Actual funding decisions vary.
Direct collaborators. Node size = influence, colour = community, dashed = past collaboration.
bioRxiv (Cold Spring Harbor Laboratory) · 2026-06-08
International Journal of Biological Macromolecules · 2026-03-01
Paneth-like transition drives resistance to dual targeting of KRAS and EGFR in colorectal cancer
Cancer Cell · 2025-11-13 · 14 citations
The Journal of Immunology · 2025-11-01
Immunity · 2025-07-31 · 8 citations
Metal-organic framework nanomaterials alter cellular metabolism in bladder cancer
Ecotoxicology and Environmental Safety · 2025-05-14
Agrimonia pilosa Extract suppresses NSCLC growth through regulating PI3K/AKT/Bcl-2 pathway
Journal of Ethnopharmacology · 2025-04-29 · 5 citations
Predicting optimal endotracheal tube depth in children based on height and middle finger length
Pediatric Research · 2025-03-16
European Polymer Journal · 2025-02-12 · 16 citations
Communications Biology · 2025-01-20 · 3 citations
Sensitivity-Guided Multi-stage Sequential Quadratic Programming for Launch Sequence Optimization
Lecture notes in electrical engineering · 2025-01-01
Cardiovascular Diabetology · 2024-10-28 · 4 citations